Zai Lab (US) LLC
Commercial stage biopharmaceutical company.
Based in MA
🤖
AI Overview
With $800K in lobbying spend across 17 quarterly filings, Zai Lab (US) LLC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2022 to 2025.
$800K
Total Spend
4
Years Active
1
Firms Hired
5
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Financial, Health Issues
- •Issues regarding health care and financial services impacting the biotechnology and pharmaceutical industry.
Related Analysis
Related Investigations
Follow the Money
Tracking lobbying dollars through the financial system.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Beone Medicines USA, INC (Formerly Beigene USA, INC.)
$3.5M total spend
Sun Life Financial (U.S.) Services Company INC.
$2.3M total spend
General Catalyst Group Management, LLC
$210K total spend
State Street Bank and Trust Company and its Affiliates
$13.0M total spend
Akebia Therapeutics, INC.
$9.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.